HOME >> BIOLOGY >> NEWS
Pregnancy hormone increases nerve cells' insulation, restores damage

WASHINGTON, DC February 16, 2007 A hormone produced during pregnancy spontaneously increases myelin, which enhances signaling within the nervous system, and helps repair damage in the brain and spinal cord, according to new animal research.

The findings, published in the February 21 Journal of Neuroscience, indicate that the hormone prolactin promotes an increase in myelin production and may have a use in treating multiple sclerosis (MS).

In MS, affecting about 2.5 million people worldwide, the body's own immune system attacks myelin, which insulates nerve cells and plays a critical role in the speed at which messages are transmitted from cell to cell. Reduction in myelin leads to a progressive loss of sensation and movement in MS patients.

"Agents promoting remyelination will be beneficial not only for typical demyelinating diseases like MS," says Fred Gage, PhD, of the Salk Institute, "but also for many other neurological disorders, such as spinal cord injuries and stroke." Gage did not participate in the study.

The research was based on evidence showing that multiple sclerosis, which is more common in women than men, goes into remission when women become pregnant. "It was thought that during pregnancy, their immune systems no longer destroyed the myelin," says study author Samuel Weiss, PhD, at the Hotchkiss Brain Institute of the University of Calgary. "But no previous study has tested whether pregnancy actually results in the production of new myelin, which may explain improvement of symptoms."

Comparing pregnant and virgin female mice of the same age, Weiss's team counted hundreds of cells in their brains and spinal cords. They found that the pregnant mice had twice as many myelin-producing cells, called oligodendrocytes, and continued to generate new ones during pregnancy. After giving birth, these mice also had 50 percent more myelin coating their nerve cells.

The researchers also show
'"/>

Contact: Sara Harris
sharris@sfn.org
202-962-4000
Society for Neuroscience
20-Feb-2007


Page: 1 2

Related biology news :

1. Pregnancy nausea/vomiting may indicate lower risk of breast cancer
2. Pregnancy hormone key to repairing nerve cell damage
3. Pregnancy news -- Preterm delivery risk reduced by high-dose progesterone treatment
4. Pregnancy drugs can affect grandkids
5. Pregnancy complications related to low levels of anticlotting proteins
6. Circadian clock controls plant growth hormone
7. Role of thyroid hormones in slumber under investigation at Rutgers
8. Breast cancer and hormone therapy -- A looking-glass mirror?
9. IMS updated recommendations on postmenopausal hormone therapy
10. Fat tissue-derived hormone leptin increases e-cadherin expression, obesity-breast cancer link noted
11. Steroid hormones regulate the body clock

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
(Date:7/18/2020)... ... July 16, 2020 , ... A study has been published ... Neoasis™ active noise control device to attenuate typical noises in a simulated neonatal ... the alarm sounds from patient monitors, ventilators and other bedside devices that would ...
(Date:7/2/2020)... ... July 01, 2020 , ... AltruBio Inc. http://www.altrubio.com ... a biologic for the treatment of steroid-refractory acute graft-versus-host disease (SR-aGVHD), at European ... J Martin of the Fred Hutchinson Cancer Research Center, this single-arm, open-label Phase ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... FARMS, Mich. (PRWEB) , ... August 12, 2020 ... ... Consulting Group, Inc. (EMMA International), a global leader in FDA compliance consulting ... of the nation’s fastest-growing private companies. The list represents a unique look at ...
(Date:8/3/2020)... (PRWEB) , ... August 03, 2020 , ... ... collection, today announced Jim Corrigan, President and CEO has been named one of ... broad cross-section of industry sectors, PharmaVoice 100 honorees are selected based on how ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
Breaking Biology Technology:
Cached News: